@article{80e11b5bbd9743428bb27cb08b796b59,
title = "An analysis of the evidence underpinning the national comprehensive cancer network practice guidelines",
abstract = "Objective: This study assesses the quality and completeness of systematic reviews (SRs) included by the National Comprehensive Cancer Network (NCCN) cancer screening clinical practice guidelines (CPGs). Methods: We evaluated SRs according to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) and AMSTAR-2 (A Measurement Tool to Assess systematic Reviews). Results: Seven NCCN CPGs were included with 109 SRs. The mean PRISMA percent completeness of included SRs was 71 % (range 0.1–1.0). The mean AMSTAR-2 percent completeness was 56 % (range 0.05−0.99). Of the 70 SRs assessed via AMSTAR-2, 42 (60 %) received a “critically low” rating, 11 (15.7 %) received “low” ratings, and 17 (24.3 %) received “moderate”. None of the SRs received a “high” rating. Conclusion: Lack of adherence to AMSTAR-2 and PRISMA reporting standards among the SRs included is prevalent. We suggest improved reporting of SR inclusion criteria and evaluation to bolster the reporting quality of SRs underpinning CPG recommendations.",
keywords = "AMSTAR-2, Cancer screening, Clinical practice guidelines, PRISMA, Systematic reviews",
author = "Mitchell Love and Jordan Staggs and Corbin Walters and Cole Wayant and Trevor Torgerson and Micah Hartwell and Anderson, {J Michael} and Anna Lillie and Kate Myers and Travis Brachtenbach and Micah Derby and Matt Vassar",
note = "Funding Information: Dr. Hartwell reports receiving funding from the National Institute of Justice for work unrelated to the current subject. Dr. Vassar reports receipt of funding from the National Institute on Drug Abuse, the National Institute on Alcohol Abuse and Alcoholism, the US Office of Research Integrity, Oklahoma Center for Advancement of Science and Technology, and internal grants from Oklahoma State University Center for Health Sciences ? all outside of the present work. All other authors have no conflicts of interest to report. Funding Information: Dr. Hartwell reports receiving funding from the National Institute of Justice for work unrelated to the current subject. Dr. Vassar reports receipt of funding from the National Institute on Drug Abuse , the National Institute on Alcohol Abuse and Alcoholism , the US Office of Research Integrity , Oklahoma Center for Advancement of Science and Technology , and internal grants from Oklahoma State University Center for Health Sciences — all outside of the present work. All other authors have no conflicts of interest to report. Publisher Copyright: {\textcopyright} 2021 Elsevier B.V.",
year = "2022",
month = jan,
doi = "10.1016/j.critrevonc.2021.103549",
language = "English",
volume = "169",
journal = "Critical Reviews in Oncology/Hematology",
issn = "1040-8428",
publisher = "Elsevier Ireland Ltd",
}